Aug 25, 2025 07:30AM
Aug 25, 2025 07:30AM
May 14, 2025 04:01PM
Mar 19, 2025 04:01PM
Mar 7, 2025 06:46AM
Mar 6, 2025 04:01PM
Mar 6, 2025 04:01PM scPharmaceuticals Announces FDA Approval of Supplemental New Drug Application Expanding the FUROSCIX® Indication to Include the Treatment of Edema in Patients with Chronic Kidney Disease
Nov 13, 2024 04:01PM
Oct 15, 2024 08:30AM
Aug 19, 2024 06:50AM
Aug 14, 2024 04:01PM
Aug 12, 2024 06:04AM
Aug 12, 2024 06:04AM
Aug 12, 2024 06:02AM scPharmaceuticals (SCPH) Reports Positive Topline Study Results for SCP-111
Aug 12, 2024 06:02AM
Jul 25, 2024 08:02AM
Jul 25, 2024 08:00AM
May 14, 2024 04:01PM
Apr 24, 2024 08:00AM
Mar 13, 2024 04:01PM
Nov 8, 2023 04:01PM scPharmaceuticals Inc. Reports Third Quarter 2023 Financial Results and Provides Business Update
Sep 19, 2023 08:03AM
Sep 19, 2023 08:00AM
Aug 10, 2023 04:01PM
Aug 1, 2023 08:01AM
Aug 1, 2023 08:00AM
Jan 30, 2023 08:01AM
Jan 30, 2023 08:00AM scPharmaceuticals Provides FUROSCIX® (furosemide injection) Commercial Update
Nov 9, 2022 04:05PM
Oct 21, 2022 08:47AM
Oct 11, 2022 07:38AM
Oct 10, 2022 09:41AM
Oct 10, 2022 08:07AM
Oct 10, 2022 08:05AM
Oct 10, 2022 08:02AM scPharmaceuticals (SCPH) Announces FDA Approval of FUROSCIX, the First and Only Self-administered, Subcutaneous Loop Diuretic for the At-home Treatment of Congestion in Chronic Heart Failure
Oct 10, 2022 08:00AM
Sep 30, 2022 08:00AM
Aug 9, 2022 07:00AM
Jul 12, 2022 08:00AM
Jul 12, 2022 08:00AM
Jun 7, 2022 08:00AM
May 16, 2022 07:10AM scPharmaceuticals Inc. Reports First Quarter 2022 Financial Results and Provides Business Update
May 16, 2022 07:00AM
Apr 11, 2022 07:07AM
Apr 11, 2022 07:00AM
Mar 22, 2022 07:00AM
Mar 1, 2022 04:05PM
Mar 1, 2022 04:05PM
Nov 9, 2021 07:00AM scPharmaceuticals Inc. Reports Third Quarter 2021 Financial Results and Provides Business Update
Sep 10, 2021 08:03AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All